Eurofins DiscoverX

Generate functional, quantitative assay data in just three easy steps. Thaw. Plate. Run! Explore how ready-to-use, no-wash eXpress™ cell-based assay kits help drug discovery teams to move quickly from target identification to lead optimization. Eurofins DiscoverX eXpress Assay Kits: - Screen targets & identify promising activity - Confirm functional responses & mechanism of action (MOA) - Rank compounds & prioritize the next stage of discovery 🎥 WATCH the latest video & learn how researchers are simplifying early drug discovery with a homogeneous assay workflow that delivers sensitive & reproducible functional data.

FIRST Collaborative GPCR #Podcast! The GPCR resurgence is here & physiological relevance is at the center of it. The new podcast from Eurofins DiscoverX & Dr. GPCR features Jane Lamerdin, Gaurav Agrawal, Ph.D., & Yamina Berchiche discussing why target expression, cellular context, & receptor biology are critical for generating data that translates to the clinic. From obesity therapeutics & GLP-1 biology to the complexities of amylin receptors, discover what's driving renewed excitement in #GPCRdrugdiscovery. 🎙️ Now live! Listen in & learn what's shaping the next wave of GPCR innovation including personal GPCR-related experiences from the speakers. https://lnkd.in/gpr6qqY8 #GPCR #DrugDiscovery #ObesityResearch #AssayDevelopment #Biotech #GPCRPodcast

New #WhitePaper - GPCR Functional ‘Volume Control’ in Cell Systems! Are your GPCR assays revealing the complete pharmacological profile of your compounds? A new white paper explores how functional “volume control” approaches can tune receptor density & system sensitivity to uncover hidden compound activities, quantify efficacy, & better characterize allosteric modulators. Authored by GPCR expert Terry Kenakin in collaboration with the team at Eurofins DiscoverX, this white paper is a must-read for all GPCR researchers. Obtain your free copy today!

Rapidly assess #kinaseinhibitors with validated & ready-to-use HitHunter® Kinase Enzyme Activity Assay Kits. These kits offer high specificity & sensitivity needed to measure specific #kinase #enzymeactivity in a simple user-friendly & ready-to-assay format. The newly launched Kinase Enzyme Activity Assay kits support the development of novel & safer #kinaseinhibitortherapeutics with the ability to accurately determine enzyme activity for inhibitor selectivity & potency assessments. Start accelerating kinase inhibitor therapeutics

Rapidly assess #kinaseinhibitors with validated & ready-to-use HitHunter® Kinase Enzyme Activity Assay Kits. These kits offer high specificity & sensitivity needed to measure specific #kinase #enzymeactivity in a simple user-friendly & ready-to-assay format. The newly launched Kinase Enzyme Activity Assay kits support the development of novel & safer #kinaseinhibitortherapeutics with the ability to accurately determine enzyme activity for inhibitor selectivity & potency assessments. Start accelerating kinase inhibitor therapeutics

Free #Webinar | Assessing Signaling Bias for GPCR Therapeutics Discovery & Development 📅 June 25, 2026, | 8AM PST / 11AM EST / 3PM GMT Signaling bias (functional selectivity) is emerging as a critical property of next-generation #GPCR drug candidates for safer therapeutic & pharmacological outcomes. And with the right functional assays, #signalingbias can be measured & quantified for better lead selection & optimization. Join Terry Kenakin & the team at Eurofins DiscoverX® to: - Understand what GPCR ligand-dependent signaling reveals about drug candidates - Detect & quantify GPCR signaling bias using reliable functional assays - Apply functional selectivity as a practical decision-making tool in drug discovery Register now, https://lnkd.in/gkKGbazT